Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 12, 2021 4:38pm
145 Views
Post# 33998746

House Positions since Sept 13th (Big Picture)

House Positions since Sept 13th (Big Picture)
House Positions for C:ARCH from 20210913 to 20211012
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 432,100 777,331 1.799 50,900 90,983 1.787 381,200 -686,348
85 Scotia 98,312 174,027 1.77 14,300 25,133 1.758 84,012 -148,894
83 Mackie 65,000 112,000 1.723 0   65,000 -112,000
79 CIBC 54,479 104,846 1.925 9,616 18,581 1.932 44,863 -86,265
89 Raymond James 34,732 66,273 1.908 20,100 43,366 2.158 14,632 -22,907
9 BMO Nesbitt 93,693 162,198 1.731 82,650 161,961 1.96 11,043 -237
2 RBC 45,157 84,511 1.871 35,086 63,910 1.822 10,071 -20,601
13 Instinet 11,300 24,137 2.136 4,600 9,841 2.139 6,700 -14,296
124 Questrade 9,544 17,144 1.796 3,150 5,415 1.719 6,394 -11,729
39 Merrill Lynch 960 1,987 2.07 0   960 -1,987
80 National Bank 22,576 41,683 1.846 21,734 38,057 1.751 842 -3,626
7 TD Sec 106,082 206,235 1.944 105,524 189,064 1.792 558 -17,171
57 Interactive 400 756 1.89 0   400 -756
88 Credential 390 781 2.003 0   390 -781
84 Ind Trading 307 553 1.801 399 756 1.895 -92 203
19 Desjardins 100 172 1.72 278 606 2.18 -178 434
68 Leede 1,400 2,562 1.83 2,096 3,868 1.845 -696 1,306
74 GMP 0   1,000 2,050 2.05 -1,000 2,050
33 Canaccord 11,500 20,124 1.75 15,000 25,377 1.692 -3,500 5,253
53 Morgan Stanley 54 103 1.907 5,200 8,897 1.711 -5,146 8,794
16 Paradigm 0   10,000 16,800 1.68 -10,000 16,800
90 Barclays 0   15,000 25,725 1.715 -15,000 25,725
14 ITG 10,558 19,397 1.837 26,811 49,289 1.838 -16,253 29,892
143 Pershing 0   94,400 169,422 1.795 -94,400 169,422
1 Anonymous 175,242 324,559 1.852 656,042 1,192,284 1.817 -480,800 867,725
TOTAL 1,173,886 2,141,379 1.824 1,173,886 2,141,385 1.824 0 6

<< Previous
Bullboard Posts
Next >>